journal article·2016-06

Developing 3D Scaffolds in the Field of Tissue Engineering to Treat Complex Bone Defects

Lucas D. Albrecht, Stephen W. Sawyer, Pranav Soman

Publisher page

Abstract

Polymers have been extensively used to develop 3D scaffolds in the field of tissue engineering and consist of certain design requirements such as biocompatibility, structural properties, and varying porosity inside of complex geometries, all with the ultimate goal of incorporating living cells within the scaffold structure. In this work, we present the synthesis and material characterization of hybrid spools using polycaprolactone (PCL) as the base polymer. We demonstrate that a commercial 3D Fused Deposition Modeling printer such as MakerBot can be used to print 3D scaffolds using three types of polymer spools: PCL, PCL-poly lactic acid, and PCL-hydroxyapatite. Data derived from computer tomography can be used to develop hollow porous cages using PCL. Finally, we demonstrate that log-pile scaffolds are capable of being infused with a mixture of living cells and gelatin hydrogel and that high cellular viability is maintained throughout the printed structure. This work could be potentially useful in the treatment of patients with complex bone defects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Bone Tissue Engineering Materials · Additive Manufacturing and 3D Printing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York.

References (25)

Show source-provided references
1. 10.1016/j.biotechadv.2012.10.00310.1016/j.biotechadv.2012.10.003 ↗
2. DombAJ, KostJ, WisemanD. Handbook of biodegradable polymers. CRC Press, Amsterdam, Netherlands, 1998.
3. 10.1016/S0142-9612(00)00121-610.1016/S0142-9612(00)00121-6 ↗
4. 10.1002/term.1810.1002/term.18 ↗
5. 10.1108/RPJ-03-2012-002310.1108/RPJ-03-2012-0023 ↗
6. Trachtenberg JE · J Biomed Mater Res Part A · 2014 · 102 · 4326
7. 10.1002/jps.2105910.1002/jps.21059 ↗
8. 10.1080/0785389070188178810.1080/07853890701881788 ↗
9. 10.1016/j.biomaterials.2012.04.05010.1016/j.biomaterials.2012.04.050 ↗
10. 10.1016/j.biomaterials.2004.11.05710.1016/j.biomaterials.2004.11.057 ↗
11. 10.1002/jbm.b.1048510.1002/jbm.b.10485 ↗
12. 10.1108/RPJ-04-2012-003710.1108/RPJ-04-2012-0037 ↗
13. 10.1016/j.cad.2005.02.00610.1016/j.cad.2005.02.006 ↗
14. 10.1088/1758-5082/4/2/02500910.1088/1758-5082/4/2/025009 ↗
15. 10.1016/j.tibtech.2004.05.00510.1016/j.tibtech.2004.05.005 ↗
16. 10.1002/adma.20050144710.1002/adma.200501447 ↗
17. 10.1108/1355254041051252510.1108/13552540410512525 ↗
18. 10.1007/s10856-012-4738-810.1007/s10856-012-4738-8 ↗
19. 10.1016/j.mattod.2013.11.01710.1016/j.mattod.2013.11.017 ↗
20. 10.1016/j.biomaterials.2010.03.06410.1016/j.biomaterials.2010.03.064 ↗
21. 10.1002/bit.2495710.1002/bit.24957 ↗
22. 10.1007/s10856-008-3671-310.1007/s10856-008-3671-3 ↗
23. 10.1016/j.biomaterials.2007.08.01810.1016/j.biomaterials.2007.08.018 ↗
24. 10.1016/j.ijbiomac.2010.03.01510.1016/j.ijbiomac.2010.03.015 ↗
25. 10.1016/S1350-4533(98)00007-110.1016/S1350-4533(98)00007-1 ↗